Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 28;16(12):1529.
doi: 10.3390/pharmaceutics16121529.

Organic Moiety on Sn(IV) Does Matter for In Vitro Mode of Action: n Bu3Sn(IV) Compounds with Carboxylato N-Functionalized 2-Quinolones Induce Anoikis-like Cell Death in A375 Cells

Affiliations

Organic Moiety on Sn(IV) Does Matter for In Vitro Mode of Action: n Bu3Sn(IV) Compounds with Carboxylato N-Functionalized 2-Quinolones Induce Anoikis-like Cell Death in A375 Cells

Marijana P Kasalović et al. Pharmaceutics. .

Abstract

Objectives: New tributyltin(IV) complexes containing the carboxylate ligands 3-(4-methyl-2-oxoquinolin-1(2H)-yl)propanoic acid (HL1) and 2-(4-methyl-2-oxoquinolin-1(2H)-yl)acetic acid (HL2) have been synthesized. Methods: Their structures have been determined by elemental microanalysis, FT-IR and multinuclear NMR (1H, 13C and 119Sn) spectroscopy and X-ray diffraction study. A solution state NMR analysis reveals a four-coordinated tributyltin(IV) complex in non-polar solvents, while an X-Ray crystallographic analysis confirms a five-coordinated trigonal-bipyramidal geometry around the tin atom due to the formation of 1D chains. A theoretical structural analysis was performed by optimization employing B3LYP-D3BJ functional and 6-311++G(d,p)/def2-TZVP(Sn) basis sets for H, C, N, O/Sn, respectively. The interactions between tin(IV) and surrounding atoms were examined by QTAIM approach. The in vitro antiproliferative activity of the synthesized compounds was evaluated by MTT and CV assays versus MCF-7 (human breast adenocarcinoma), HCT116 (human colorectal carcinoma), A375 (human melanoma), 4T1 (mouse breast carcinoma), CT26 (mouse colon carcinoma) and B16 (mouse melanoma) tumor cell lines. Results: Both synthesized compounds (nBu3SnL1 and nBu3SnL2) exerted powerful micromolar IC50 cytotoxicity values and demonstrated high selectivity toward malignant cells. Both experimental drugs affected cell adhesion and induced anchorage independent apoptosis, a favorable type of cell death with an essential role in cancer dissemination prevention. The BSA-binding affinity of the obtained organotin compounds was followed by spectrofluorometric titration and molecular docking simulations. Conclusions: The tributyltin(IV) compounds selectively induce anoikis-like cell death in A375 cells, also highlighting the importance of the organic moiety on the tin(IV) ion in the mechanism of action.

Keywords: 2-quinolones; BSA interactions; apoptosis; in vitro cytotoxicity; molecular docking; tributyltin(IV) compounds.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Scheme 1
Scheme 1
Synthesis of the ligand precursors, HL1 and HL2 [39], and tributyltin(IV) compounds, nBu3SnL1 and nBu3SnL2. The numbering of atoms was used for NMR assignation and matched the one applied in the X-ray study of nBu3SnL2.
Figure 1
Figure 1
ORTEP diagram (25% probability ellipsoids) of a selected part of the chain formed by nBu3SnL2 in the solid state. All hydrogen atoms are omitted for clarity and, of disordered atoms, only one atomic position is shown. Symmetry codes: “A” = ½ − x, y + ½, ½ − z; “B” = ½ − x, −½ + y, ½ − z.
Figure 2
Figure 2
Optimized structures of organotin compounds at B3LYP-D3BJ/6-311++G(d,p)(H,C,N,O)/def2-TZVP(Sn) level of theory: (a) nBu3SnL1, (b) nBu3SnL2 (Hydrogen—white, carbon—gray, nitrogen—blue, oxygen—red, tin—dark green).
Figure 3
Figure 3
Experimental (black) and theoretical IR spectra (blue) of investigated compounds: (a) nBu3SnL1, (b) nBu3SnL2 (at B3LYP-D3BJ/6-311++G(d,p)(H,C,N,O)/def2-TZVP(Sn) level of theory).
Figure 4
Figure 4
Compounds nBu3SnL1 and nBu3SnL2 induced anchorage independent apoptosis in A375 cultures. A375 cells were exposed to an IC50 dose of compounds nBu3SnL1 and nBu3SnL2, and flow cytometry of Ann/PI-stained cells was performed after (a) 72 h treatment and (b) 48 h treatment.
Figure 5
Figure 5
PI staining on chamber slides after 48 h treatment of A375 cells with compounds nBu3SnL1 and nBu3SnL2 (IC50 dose).
Figure 6
Figure 6
Compounds nBu3SnL1 and nBu3SnL2 affected the adhesion and ROS/RNS production. (a) A375 cell adhesion on Matrigel® and (b) ROS/RNS production (* and ** are for p < 0.05, p < 0.01, respectively).
Figure 7
Figure 7
Fluorescence emission spectra of BSA for the titration with nBu3SnL2 at (a) 27°, (b) 32°, (c) 37°, and (d) Van ’t Hoff plot for the binding process.
Figure 7
Figure 7
Fluorescence emission spectra of BSA for the titration with nBu3SnL2 at (a) 27°, (b) 32°, (c) 37°, and (d) Van ’t Hoff plot for the binding process.
Figure 8
Figure 8
The most stable positions of (a) nBu3SnL1 and (b) nBu3SnL2 compounds within BSA structure.
Figure 9
Figure 9
The most important interactions between organotin(IV) compounds (a) nBu3SnL1 and (b) nBu3SnL2 and BSA in the active pockets close to Trp213. Different colors of the interactions represent the following: van der Waal interactions and carbon–hydrogen bonds—light green; conventional hydrogen bonds—dark green; π–alkyl—orange; π–π stacked—dark pink; alkyl and π–alkyl—light pink (Hydrogen—white, carbon—gray, nitrogen—blue, oxygen—red, tin—dark green).

Similar articles

References

    1. Alama A., Tasso B., Novelli F., Sparatore F. Organometallic Compounds in Oncology: Implications of Novel Organotins as Antitumor Agents. Drug Discov. Today. 2009;14:500–508. doi: 10.1016/j.drudis.2009.02.002. - DOI - PubMed
    1. Cherek P., Balogova M., Damodaran K., Ögmundsdottir H.M. Abstract 2807: Cytotoxic Activity of Novel Organotin Compounds against Different Cancer Cell Lines. Cancer Res. 2018;78:2807. doi: 10.1158/1538-7445.AM2018-2807. - DOI
    1. Gielen M., Biesemans M., Willem R. Organotin Compounds: From Kinetics to Stereochemistry and Antitumour Activities. Appl. Organomet. Chem. 2005;19:440–450. doi: 10.1002/aoc.771. - DOI
    1. Zhang C., Xu C., Gao X., Yao Q. Platinum-Based Drugs for Cancer Therapy and Anti-Tumor Strategies. Theranostics. 2022;12:2115–2132. doi: 10.7150/thno.69424. - DOI - PMC - PubMed
    1. Ott I., Gust R. Non Platinum Metal Complexes as Anti-Cancer Drugs. Arch. Pharm. 2007;340:117–126. doi: 10.1002/ardp.200600151. - DOI - PubMed

LinkOut - more resources